The Half-Life of Serum Des-Gamma-Carboxy Prothrombin Is a Prognostic Index of Survival and Recurrence After Liver Resection for Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

The Half-Life of Serum Des-Gamma-Carboxy Prothrombin Is a Prognostic Index of Survival and Recurrence After Liver Resection for Hepatocellular Carcinoma

Published:2016-09-14 Issue:S5 Volume:23 Page:921-928
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Okamura Yukiyasu,Sugiura Teiichi,Ito Takaaki,Yamamoto Yusuke,Ashida Ryo,Uesaka Katsuhiko

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-016-5570-z.pdf

Reference20 articles.

1. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–2.

2. Shimada M, Takenaka K, Gion T, et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology. 1996;111:720–6.

3. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg. 1999;229:16–22.

4. Liaw YF, Tai DI, Chu CM, Lin DY, Sheen IS, Chen TJ, et al. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis: a prospective study. Gastroenterology. 1986;90:263–7.

5. Debruyne EN, Delanghe JR. Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin Chim Acta. 2008;395:19–26.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined PIVKA II and Vimentin-Guided EMT Tracking in Pancreatic Adenocarcinoma Combined Biomarker-Guided EMT Tracking in PDAC;Cancers;2024-06-27

2. Deciphering the Influence of Ap1m2 in Modulating Hepatocellular Carcinoma Growth and Mobility Through Jnk/Erk Signaling Pathway Control;2024

3. Deciphering the Influence of AP1M2 in Modulating Hepatocellular Carcinoma Growth and Mobility through JNK/ErK Signaling Pathway control;2023-10-13

4. Long-term outcome and eligibility of radiofrequency ablation for hepatocellular carcinoma over 3.0 cm in diameter;Scientific Reports;2023-09-28

5. Longitudinal surveillance of three biomarkers to predict recurrence of hepatocellular carcinoma after radical resection;European Journal of Gastroenterology & Hepatology;2023-07-11